Paul J Declerck (Paul Declerck)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 25

Top Topics

Ulcerative Colitis

Saccharomyces Cerevisiae

Top Venues

International journal of molecular sciences

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jolien Breukers, Karen Ven, Caroline Struyfs, Louanne Ampofo, Iene Rutten, Maya Imbrechts, Francesca Pollet, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik-Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, Paul J Declerck, Bruno P A Cammue, Nick Geukens, Karin Thevissen, Jeroen Lammertyn
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small methods (2023)
Jolien Breukers, Karen Ven, Caroline Struyfs, Louanne Ampofo, Iene Rutten, Maya Imbrechts, Francesca Pollet, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik-Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, Paul J Declerck, Bruno P A Cammue, Nick Geukens, Karin Thevissen, Jeroen Lammertyn
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small methods 7 (3) (2023)
Jolien Breukers, Karen Ven, Caroline Struyfs, Louanne Ampofo, Iene Rutten, Maya Imbrechts, Francesca Pollet, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik-Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, Paul J Declerck, Bruno P A Cammue, Nick Geukens, Karin Thevissen, Jeroen Lammertyn
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small methods 7 (3) (2023)
Jolien Breukers, Karen Ven, Caroline Struyfs, Louanne Ampofo, Iene Rutten, Maya Imbrechts, Francesca Pollet, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik-Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, Paul J Declerck, Bruno P A Cammue, Nick Geukens, Karin Thevissen, Jeroen Lammertyn
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small methods 7 (3) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Jolien Breukers, Karen Ven, Caroline Struyfs, Louanne Ampofo, Iene Rutten, Maya Imbrechts, Francesca Pollet, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik-Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, Paul J Declerck, Bruno P A Cammue, Nick Geukens, Karin Thevissen, Jeroen Lammertyn
FLUIDOT: A Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining. Small methods 7 (3) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Marie-Lynn Cuypers, Nick Geukens, Kevin Hollevoet, Paul J Declerck, Maarten Dewilde
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice. Pharmaceutics 15 (4) (2023)
Sebastian Berge-Seidl, Nis Valentin Nielsen, Armando Alexei Rodríguez, Michael Etscheid, Sai Priya Sarma Kandanur, Bengt Erik Haug, Maria Stensland, Bernd Thiede, Merve Karacan, Nico Preising, Sebastian Wiese, Ludger Ständker, Paul J Declerck, Geir Åge Løset, Sandip M Kanse
Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation. ACS chemical biology 17 (9) (2022)
Rani Soenen, Zhigang Wang, Lynda Grine, Erwin Dreesen, Lisa Schots, Els Brouwers, Paul J Declerck, Debby Thomas, Jo Lydie Wilfried Lambert
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis. Clinical and experimental dermatology 47 (7) (2022)
Laurence Venisse, Déborah François, Célina Madjène, Els Brouwers, Emmanuelle de Raucourt, Yacine Boulaftali, Paul J Declerck, Véronique Arocas, Marie-Christine Bouton
Novel ELISA for the specific detection of protease NEXIN-1 in human biological samples. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Nathalie Van den Berghe, Bram Verstockt, Ann Gils, João Sabino, Marc Ferrante, Séverine Vermeire, Paul J Declerck, Debby Thomas
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab Concentrations. Journal of Crohn's & colitis 15 (6) (2021)
Machteld Sillen, Toshio Miyata, Douglas E Vaughan, Sergei V Strelkov, Paul J Declerck
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484. International journal of molecular sciences 22 (3) (2021)
Machteld Sillen, Paul J Declerck
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? International journal of molecular sciences 22 (5) (2021)
Qin Zhou, Lei Zhao, Zhifei Shao, Paul J Declerck, Lawrence L K Leung, John Morser
Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice. Journal of thrombosis and haemostasis : JTH (2021)
Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul J Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis. Pharmaceutics 13 (10) (2021)
Liesl Jacobs, Lidia Yshii, Steffie Junius, Nick Geukens, Adrian Liston, Kevin Hollevoet, Paul J Declerck
Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response. Cancer gene therapy (2021)
Machteld Sillen, Paul J Declerck
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. International journal of molecular sciences 22 (7) (2021)
Liese Barbier, Yannick Vandenplas, Steven R A Simoens, Paul J Declerck, Arnold G Vulto, Isabelle Huys
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians. Journal of pharmaceutical policy and practice 14 (1) (2021)
Julie Van Lent, Jolien Breukers, Karen Ven, Louanne Ampofo, Sara Horta, Francesca Pollet, Maya Imbrechts, Nick Geukens, Karen Vanhoorelbeke, Paul J Declerck, Jeroen Lammertyn
Miniaturized single-cell technologies for monoclonal antibody discovery. Lab on a chip 21 (19) (2021)
Machteld Sillen, Stephen D Weeks, Sergei V Strelkov, Paul J Declerck
Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity. International journal of molecular sciences 21 (16) (2020)
Giles Vermeire, Elien De Smidt, Peter Casteels, Nick Geukens, Paul J Declerck, Kevin Hollevoet
DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration. Cancer gene therapy 28 (7-8) (2020)
Machteld Sillen, Stephen D Weeks, Xiaohua Zhou, Andrey A Komissarov, Galina Florova, Steven Idell, Sergei V Strelkov, Paul J Declerck
Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction. Journal of thrombosis and haemostasis : JTH 18 (3) (2020)
Tobias Kromann-Hansen, Eva Louise Lange, Hans Peter Sørensen, Gholamreza Hassanzadeh-Ghassabeh, Mingdong Huang, Jan K Jensen, Serge Muyldermans, Paul J Declerck, Elizabeth A Komives, Peter A Andreasen
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator. Scientific reports 7 (1) (2017)
Tine Wyseure, Marina Rubio, Frederik Denorme, Sara Martinez de Lizarrondo, Miet Peeters, Ann Gils, Simon F De Meyer, Denis Vivien, Paul J Declerck
Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke. Blood 125 (8) (2014)